Avelumab is a human IgG1 monoclonal antibody targeting PD-L1, capable of inducing antibody-dependent cellular cytotoxicity (ADCC). It is utilized in research applications, including in vitro immune checkpoint blockade studies and in vivo models investigating its antitumor activity.
Konzentration:
7.76 mg/mL
Molekulargewicht:
143.8 kDa
Reinheit:
98.30% (May vary between batches)
CAS Nummer:
[1537032-82-8]
Target-Kategorie:
PD-1/PD-L1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten